Summary report of the SF e-meeting, September 16, 2014
Meeting objective: EUnetHTA Conference preparation, Interim reporting and update on Exec Comm meeting 20140916_Stakeholderforum_e-meeting_minutes_final.pdf
Summary report of the SF e-meeting, November 18, 2014
Meeting objectives: Update EUnetHTA Conference; EUnetHTA recommendations; HTA Network update; Stakeholder training 20141118_Stakeholderforum_e-meeting_final minutes.pdf
Summary report of the SF face-to-face-meeting, February 26, 2015
Meeting objectives: JA2 status; Update on Early dialogues; HTA Network update; JA3 update on information preparations; Stakeholder involvement lessons learned 20150226_EUnetHTA JA2_SF_F-t-Fmeeting_Brussels_Summary_final.pdf
Summary report of the SF e-meeting, September 8, 2015
Meeting objective: National uptake; Finalisation of JA2; JA3 update; HTA Network update 20150908_Stakeholderforum_e-meeting_final minutes.pdf
Summary report of the SF e-meeting, May 12, 2015
Meeting objectives: JA2 updates; HTA Network update; JA3 preparations; finalising JA2 20150512_Stakeholderforum_e-meeting_final minutes.pdf
WP7 SG2 Position paper on how to decide on the appropriate study design for AEG available
WP7 Subgroup 2 is pleased to announce the publication of the Position paper on how to decide on the appropriate study design for primary research arising from HTA reports. This document is one of two WP7 SG2 methodological documents aiming to help HTA authors/systematic reviewers in defining their recommendations for Additional Evidence Generation (AEG). This […]
WP7 SG2 Position paper on how to best formulate research recommendations for AEG
This document is one of two WP7 SG2 methodological documents aiming to help HTA authors/systematic reviewers in defining their recommendations for Additional Evidence Generation (AEG). It is focusing on providing a structured approach for the identification of research gaps and improving the presentation of research recommendations arising from HTA reports. Both uncertainties related to the […]
WP7-SG3 “Therapeutic medical devices” guideline
This guideline on “Therapeutic medical devices”, with answered comments from the SAG / Public consultation, is the last guideline of WP7 Subgroup 3 in JA2. Comments_answers_GL_Ther_medical_devices Therapeutic medical devices_Guideline_Final Nov 2015
WP7 SG2 Core protocol Pilot for AEG available
WP7 Subgroup 2 is pleased to announce the publication of its final deliverable – the Core protocol Pilot for Additional Evidence Generation (AEG). This pilot consists of two parts: – Defining core elements of a study protocol for AEG and developing the template of a Core protocol for AEG (section 1) – Testing the developed […]
WP5 Strand A – Procedure Manual V 4
This document describes processes planned for conducting pilot rapid assessments for pharmaceuticals. Since the Procedure Manual is a living document, further changes can be expected due to experiences gathered throughout JA2. 2012123627 – Procedure_manual_REA pilots_WP5_Strand A
